Update - NICE decision re Dinutuximab beta

Written By Guest User

The NICE committee meeting to discuss Dinutuximab beta, held on Tuesday 12th June 2018, was attended by Tony Heddon, Chair, Neuroblastoma UK. The meeting was constructive and a final decision on whether Dinutuximab beta will be funded by the NHS is expected in the next 5 – 10 days.

Guest User
Previous

NICE approves neuroblastoma drug
Next

Neuroblastoma charities unite to beat cancer